U.S. Markets closed

Psychemedics Corporation (PMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.27-0.37 (-5.57%)
At close: 04:00PM EDT
6.20 -0.07 (-1.12%)
After hours: 06:09PM EDT

Psychemedics Corporation

289 Great Road
Suite 200
Acton, MA 01720
United States
978 206 8220

IndustryDiagnostics & Research
Full Time Employees139

Key Executives

NameTitlePayExercisedYear Born
Mr. Raymond C. KubackiChairman, CEO & Pres473.2kN/A1945
Mr. Charles M. Doucot IVExec. VP262.75kN/A1966
Dr. Michael I. Schaffer Ph.D.VP of Laboratory Operations248.02kN/A1945
Dr. Werner A. Baumgartner Ph.D.FounderN/AN/AN/A
Ms. Annette BaumgartnerFounderN/AN/AN/A
Mr. Andrew LimbekVP of Fin. & ControllerN/AN/A1986
Ms. Sarah AshbyVP & Gen. CounselN/AN/AN/A
Mr. Patrick J. Kinney Jr.Sec.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.

Corporate Governance

Psychemedics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.